Sayer Ji, Founder
September 27, 2013


A new study published in JAMA Ophthalmology titled, "Association of Statin Use With Cataracts: A Propensity Score-Matched Analysis," reveals that the top-grossing, cholesterol-lowering drug class known as statins is significantly increasing the risk of cataracts within exposed populations.[1]

Statin-induced eye damage will be a surprising finding to some, especially to statin drug advocates who have argued that the purported 'antioxidant' effects of statins 'may slow the natural aging process of the lens.' This latter, strictly theoretical benefit is increasingly being disproved by the biomedical literature. In fact, last year, we reported in an article titled, "Blind To The Truth: The Eye-Damaging Effects of Statins," on findings published in Optometry and Vision Science, revealing that statin drugs users have a 48% higher risk of pathological eye lens changes commonly associated with cataract formation.

To read the rest of the article go to:
http://www.greenmedinfo.com/blog/cho...20323-86749061